Back HIV/AIDS HIV/AIDS Topics HIV Treatment Conferences AIDS 2014

IAS 2015: International AIDS Society Conference Starts this Weekend in Vancouver

The 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) starts this Sunday and runs July 19-22 in Vancouver. HIV prevention -- including treatment-as-prevention and pre-exposure prophylaxis (PrEP) -- will be a major focus of the meeting. Other topics will include antiretroviral drugs in development, expanding access to treatment and retention in care, and HIV/hepatitis coinfection. HIVandHepatitis.com will be on site covering the latest news.

alt

Read more:

14. HIV Researchers and Advocates Killed in Plane Crash En Route to AIDS Conference

The 2014 International AIDS Conference in Melbourne got off to a somber start in July after several HIV researchers and advocates en route to the meeting were killed on Malaysian Airlines flight MH17 from Amsterdam to Kuala Lumpur, which crashed after being hit by a missile near the Russia-Ukraine border.alt

Read more:

Counseling Helps Improve PrEP Adherence Among Serodiscordant Couples

Cognitive-behavioral counseling sessions significantly increased the likelihood of consistently taking pills among participants with faltering adherence in an African trial of Truvada pre-exposure prophylaxis (PrEP) for serodiscordant (mixed HIV status) heterosexual couples, according to a report in the August 15 Journal of Acquired Immune Deficiency Syndromes.

alt

Read more:

HIV and Hepatitis C Highlights from AIDS 2014

Latest Positive Pulse Newsletter

Paul Sax from Harvard Medical School and Mark Sulkowski from Johns Hopkins School of Medicine discuss highlights from this summer's International AIDS Conference, the largest and most comprehensive global meeting on the medical, public health, and social aspects of HIV and AIDS.

Highlights of this overview include the HIV cascade of care, developments in antiretroviral therapy, pre-exposure prophylaxis (PrEP) and other HIV prevention news, and new hepatitis C treatment for people with HIV/HCV coinfection.

10/22/14

alt

AIDS 2014: Low Level Viral Load Does Not Raise Risk of HIV Treatment Failure

People with HIV who have a low-level viral load between 20 and 50 copies/mL were not more likely to experience virological failure of antiretroviral therapy (ART) compared with those who consistently maintained viral suppression below 20 copies/mL, according to research presented at the 20th International AIDS Conference in Melbourne.

alt

Read more:

AIDS 2014: Most Gay Men Who Don’t Use Condoms Attempt to Reduce HIV Risk

Three-quarters of Australian gay and bisexual men who report unprotected anal intercourse with casual male partners say that they often or always employ some sort of risk reduction strategy with those partners, according to a report at the 20th International AIDS Conference in Melbourne. Many men attempt to select partners who they believe have the same HIV status as themselves (serosorting), a significant proportion use condoms most but not all of the time, and smaller numbers practice "strategic positioning" or withdrawal before ejaculation.

alt

Read more:

AIDS 2014: Australian Bone Marrow Transplant Patients Show No Detectable HIV

An additional 2 people with long-term HIV infection have no evidence of infectious virus or viral genetic material following bone marrow stem cell transplants to treat leukemia or lymphoma, researchers reported at the 20th International AIDS Conference last month in Melbourne. While these individuals remain on antiretroviral therapy (ART) and therefore cannot be considered functionally cured, they offer further evidence that HIV may be controlled off ART in some cases.

alt

Read more:

More Articles...